Change search
ReferencesLink to record
Permanent link

Direct link
Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose
Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.
Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands.
Show others and affiliations
2014 (English)In: Archives of Toxicology, ISSN 0340-5761, E-ISSN 1432-0738, Vol. 88, no 3, 637-646 p.Article in journal (Refereed) Published
Abstract [en]

Risk assessment for mixtures of dioxin-like compounds uses the toxic equivalency factor (TEF) approach. Although current WHO-TEFs are mostly based on oral administration, they are commonly used to determine toxicity equivalencies (TEQs) in human blood or tissues. However, the use of "intake" TEFs to calculate systemic TEQs in for example human blood, has never been validated. In this study, intake and systemic relative effect potencies (REPs) for 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD), 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF), 3,3',4,4',5-pentachlorobiphenyl (PCB-126), 2,3',4,4',5-pentachlorobiphenyl (PCB-118) and 2,3,3',4,4',5-hexachlorobiphenyl (PCB-156) were compared in rats. The effect potencies were calculated based on administered dose and liver, adipose or plasma concentrations in female Sprague-Dawley rats 3 days after a single oral dose, relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Hepatic ethoxyresorufin-O-deethylase activity and gene expression of Cyp1a1, 1a2, 1b1 and aryl hydrocarbon receptor repressor in liver and peripheral blood lymphocytes were used as endpoints. Results show that plasma-based systemic REPs were generally within a half log range around the intake REPs for all congeners tested, except for 4-PeCDF. Together with our previously reported systemic REPs from a mouse study, these data do not warrant the use of systemic REPs as systemic TEFs for human risk assessment. However, further investigation for plasma-based systemic REPs for 4-PeCDF is desirable.

Place, publisher, year, edition, pages
Heidelberg, Germany: Springer, 2014. Vol. 88, no 3, 637-646 p.
Keyword [en]
Dibenzofurans, Dioxins, PCBs, Systemic REPs, TEF concept
National Category
Chemical Sciences Pharmacology and Toxicology
URN: urn:nbn:se:umu:diva-87392DOI: 10.1007/s00204-013-1186-2ISI: 000331653200009OAI: diva2:709156
Available from: 2014-03-31 Created: 2014-03-31 Last updated: 2014-03-31Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Andersson, Patrik
By organisation
Department of Chemistry
In the same journal
Archives of Toxicology
Chemical SciencesPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 41 hits
ReferencesLink to record
Permanent link

Direct link